Evidence map›Paper›PMID 42911332›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2027

Methodological Approaches for the Preservation of Akkermansia muciniphila as Microbial Genetic Resource.

Haydee Eliza Romero-Luna, Audry Peredo-Lovillo, Guadalupe Luna-Solano, Carlos Alberto Cruz-Cruz, Carlos Eduardo Lara-Hidalgo

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Haydee Eliza Romero-LunaInstituto Tecnológico de Orizaba, Tecnológico Nacional de México, Orizaba, Veracruz, Mexico.
Audry Peredo-LovilloFacultad de Ciencias Químicas, Universidad Veracruzana, Orizaba, Veracruz, Mexico.
Guadalupe Luna-SolanoInstituto Tecnológico de Orizaba, Tecnológico Nacional de México, Orizaba, Veracruz, Mexico.
Carlos Alberto Cruz-CruzFacultad de Ciencias Químicas, Universidad Veracruzana, Orizaba, Veracruz, Mexico.
Carlos Eduardo Lara-HidalgoFacultad de Ciencias de la Salud, Universidad Anáhuac, Ciudad de México, Mexico. carlos.larahi@anahuac.mx.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Akkermansia muciniphila is part of the intestinal microbiota and uses mucin as its primary source of carbon and nitrogen. It is considered a promising next-generation probiotic, with numerous beneficial functions. It regulates metabolic functions and immune response and improves the intestinal barrier, to name a few. This translates into the prevention of diseases such as obesity and type 2 diabetes, among others. However, despite its diverse benefits, A. muciniphila presents technical challenges in its cultivation and application, such as the need for a medium with a specific composition, the bacteria's high sensitivity to oxygen, a slow growth rate and stability, as well as differences between strains. In this sense, this protocol reflects the conditions for the preservation and maintenance of A. muciniphila.

Indexed as

AkkermansiaHumansMucinsProbioticsMucinsGut microbiotaHomeostasisMucinPeriodic transfer protocolPromising probioticShort-chain fatty acids

Identifiers

PMID42911332

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.